ロード中...
Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint Inhibitors
Immune checkpoint inhibitors (ICPi) have shown their superiority over conventional therapies to treat some cancers. ICPi are effective against immunogenic tumors. However, patients with tumors poorly infiltrated with immune cells do not respond to ICPi. Combining ICPi with other anticancer therapies...
保存先:
| 出版年: | Cells |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7408477/ https://ncbi.nlm.nih.gov/pubmed/32707692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9071727 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|